-+ 0.00%
-+ 0.00%
-+ 0.00%

Atara Biotherapeutics files initial beneficial ownership statement for interim CFO Kevin Sarney

PUBT·07/06/2026 20:15:07
Listen to the news
Atara Biotherapeutics files initial beneficial ownership statement for interim CFO Kevin Sarney
  • Atara Biotherapeutics filed a Form 3 naming Kevin G. Sarney as interim CFO.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Atara Biotherapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0000905148-26-003168), on July 06, 2026, and is solely responsible for the information contained therein.